Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Glutathione in Cystic Fibrosis
NCT00506688Phase 2Completed
- Sponsor
- Mukoviszidose Institut
- Start
- Jul 2007
- Primary completion
- May 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glutathione sodium in cystic fibrosis (CF) (2 arms), sponsored by Mukoviszidose Institut. Primary endpoint: Area under the curve of FEV1 % predicted at 24 weeks. Started Jul 2007; status: completed.
02
Drugs
glutathione sodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00506688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506688.